
Biosensor Based Advanced Cancer Diagnostics
From Lab to Clinics
- 1st Edition - August 25, 2021
- Imprint: Academic Press
- Editors: Raju Khan, Arpana Parihar, S.K. Sanghi
- Language: English
- Paperback ISBN:9 7 8 - 0 - 1 2 - 8 2 3 4 2 4 - 2
- eBook ISBN:9 7 8 - 0 - 1 2 - 8 2 3 6 5 1 - 2
Early diagnosis of cancer and other non-oncological disorders gives a significant advantage for curing the disease and improving patient’s life expectancy. Recent advances in bi… Read more

Purchase options

Institutional subscription on ScienceDirect
Request a sales quoteEarly diagnosis of cancer and other non-oncological disorders gives a significant advantage for curing the disease and improving patient’s life expectancy. Recent advances in biosensor-based techniques which are designed for specific biomarkers can be exploited for early diagnosis of diseases. Biosensor Based Advanced Cancer Diagnostics covers all available biosensor-based approaches and comprehensive technologies; along with their application in diagnosis, prognosis and therapeutic management of various oncological disorders. Besides this, current challenges and future aspects of these diagnostic approaches have also been discussed. This book offers a view of recent advances and is also helpful for designing new biosensor-based technologies in the field of medical science, engineering and biomedical technology.
Biosensor Based Advanced Cancer Diagnostics
helps biomedical engineers, researchers, molecular biologists, oncologists and clinicians with the development of point of care devices for disease diagnostics and prognostics. It also provides information on developing user friendly, sensitive, stable, accurate, low cost and minimally invasive modalities which can be adopted from lab to clinics. This book covers in-depth knowledge of disease biomarkers that can be exploited for designing and development of a range of biosensors. The editors have summarized the potential cancer biomarkers and methodology for their detection, plus transferring the developed system to clinical application by miniaturization and required integration with microfluidic systems.- Covers design and development of advanced platforms for rapid diagnosis of cancerous biomarkers
- Takes a multidisciplinary approach to sensitive transducers development, nano-enabled advanced imaging, miniaturized analytical systems, and device packaging for point-of-care applications
- Offers an insight into how to develop cost-effective diagnostics for early detection of cancer
- Cover image
- Title page
- Table of Contents
- Copyright
- List of contributors
- About the editors
- Chapter 1. Cancer: A sui generis threat and its global impact
- Abstract
- 1.1 Introduction
- 1.2 Causes of cancer
- 1.3 Causes and risk factors of cancer
- 1.4 Early detection and management
- 1.5 Current management
- 1.6 Conclusions and future prospects
- Conflict of interest
- List of abbreviations
- References
- Chapter 2. Types of cancer diagnostics, the current achievements, and challenges
- Abstract
- 2.1 Introduction
- 2.2 What is cancer
- 2.3 What is diagnostics
- 2.4 Importance of diagnostics
- 2.5 Different types of cancer diagnostics
- 2.6 Factors that can amend cancer diagnostics
- 2.7 Diagnostics for some typical and mostly observed cancer types
- 2.8 Achievements, challenges, and future aim of cancer diagnostics
- Acknowledgments
- Conflict of interest
- References
- Chapter 3. Biomarkers associated with different types of cancer as a potential candidate for early diagnosis of oncological disorders
- Abstract
- 3.1 Introduction
- 3.2 Cancer biomarkers
- 3.3 Concluding remarks
- References
- Chapter 4. Biosensors: concept and importance in point-of-care disease diagnosis
- Abstract
- 4.1 Introduction
- 4.2 POC biosensors for cancer diagnosis
- 4.3 Application of biomaterials in biosensors
- 4.4 New trends in POC biosensors design
- 4.5 Commercially available POC biosensors for cancer diagnosis
- 4.6 Future perspectives
- Acknowledgments
- References
- Chapter 5. Early detection of lung cancer biomarkers through biosensor
- Abstract
- 5.1 Introduction
- 5.2 Lung cancer biomarkers
- 5.3 Biosensors for lung cancer biomarker detection
- 5.4 Conclusion and future perspectives
- References
- Chapter 6. Biosensor-based early diagnosis of hepatic cancer
- Abstract
- 6.1 Introduction
- 6.2 Hepatocellular carcinoma
- 6.3 Biosensors in cancer
- 6.4 Clinical studies on HCC serum biomarkers and their sensor-based detection
- 6.5 Other clinically relevant biomarkers for HCC
- 6.6 Conclusion
- 6.7 Future Prospects
- References
- Chapter 7. Scope and applications of biosensors in early detection of oropharyngeal cancers
- Abstract
- 7.1 Introduction
- 7.2 DNA (ct DNA)
- 7.3 Tumor necrosis factor
- 7.4 Epidermal growth factor receptor
- 7.5 Exosomes
- 7.6 Cyfra 21-1
- 7.7 Conclusion
- References
- Chapter 8. Electrochemical biosensors for early detection of cancer
- Abstract
- 8.1 Introduction
- 8.2 Biosensors
- 8.3 Electrochemical biosensors
- 8.4 Conclusion
- Acknowledgments
- References
- Further reading
- Chapter 9. Colorimetric technique-based biosensors for early detection of cancer
- Abstract
- 9.1 Introduction
- 9.2 Colorimetric-based strategy
- 9.3 Nanomaterial-based approach
- 9.4 DNA-based approach
- 9.5 Other approaches
- 9.6 Conclusion
- References
- Further reading
- Chapter 10. Magnetic properties-based biosensors for early detection of cancer
- Abstract
- 10.1 Introduction
- 10.2 Biosensors and their types
- 10.3 Cancer detection and diagnostics
- 10.4 Applications of a magnetic properties-based biosensor for cancer detection
- 10.5 Conclusion
- References
- Chapter 11. Next generation biosensors as a cancer diagnostic tool
- Abstract
- 11.1 Introduction
- 11.2 Biosensor transducers
- 11.3 Biosensors for cancer biomarker detection
- 11.4 Conclusion and discussion
- References
- Chapter 12. Microfluidics-based devices and their role on point-of-care testing
- Abstract
- 12.1 Introduction
- 12.2 Point-of-care devices
- 12.3 Nanoengineered materials
- 12.4 Microfluidic devices based on specific substrates
- 12.5 Microfluidic-based point-of-care devices for cancer diagnosing
- 12.6 Current trends and future prospects
- 12.7 Summary
- References
- Further reading
- Chapter 13. Graphene-based devices for cancer diagnosis
- Abstract
- 13.1 Introduction
- 13.2 Cancer biomarkers
- 13.3 Graphene and its derivatives
- 13.4 Graphene-based nanomaterials in cancer diagnosis
- 13.5 Functionalization of graphene for sensing application
- 13.6 Graphene material-based sensors
- 13.7 Conclusion
- References
- Chapter 14. Role of biosensor-based devices for diagnosis of nononcological disorders
- Abstract
- 14.1 Introduction
- 14.2 Biosensors for infectious diseases
- 14.3 Recent challenges and future perspectives
- 14.4 Conclusion
- References
- Chapter 15. Biosensor-based early diagnosis of gastric cancer
- Abstract
- 15.1 Introduction
- 15.2 Biomarkers for gastric cancer
- 15.3 Biosensor and gastric cancer
- 15.4 Conclusion and future perspectives
- References
- Chapter 16. 3D-printed device with integrated biosensors for biomedical applications
- Abstract
- 16.1 Introduction
- 16.2 Basics of biosensors
- 16.3 Types of biosensors
- 16.4 History of 3D-printed biosensors
- 16.5 Need of integrated biosensors
- 16.6 Commercial biosensors in the market
- 16.7 Different materials used in 3D-printed biosensors
- 16.8 Types of 3D-printing techniques
- 16.9 Applications of 3D-printed biosensors
- 16.10 Advantages of 3D-printed biosensors
- 16.11 Disadvantages of 3D-printed biosensors
- 16.12 Some of the case studies of biosensors
- 16.13 Major breakthrough in the field of personalized medicines
- 16.14 3D biosensors and cancer
- 16.15 Challenges faced by researchers
- 16.16 Regulatory aspects of biosensors
- 16.17 3D-printed biosensors in Covid-19
- 16.18 Future of 3D-integrated biosensors
- 16.19 Conclusion
- References
- Further reading
- Chapter 17. Novel paper-based diagnostic devices for early detection of cancer
- Abstract
- 17.1 Introduction
- 17.2 Formats of paper-based analytical devices
- 17.3 Fabrication and development of paper-based analytical devices
- 17.4 Diagnostic technologies
- 17.5 Current limitations
- 17.6 Conclusion and future perspectives
- References
- Further reading
- Chapter 18. Emerging technologies for salivary biomarkers in cancer diagnostics
- Abstract
- 18.1 Introduction
- 18.2 Technologies for discovery of salivary biomarkers
- 18.3 Point-of-care technologies for detection of salivary biomarkers
- 18.4 Challenges in translating salivary biomarkers to the clinics
- 18.5 Conclusion
- Acknowledgment
- References
- Chapter 19. Two-dimensional nanomaterials for cancer application
- Abstract
- 19.1 Introduction
- 19.2 Synthesis of two-dimensional nanomaterials
- 19.3 Two-dimensional nanomaterials for cancer applications
- Conclusion
- References
- Chapter 20. Challenges and future prospects and commercial viability of biosensor-based devices for disease diagnosis
- Abstract
- 20.1 Introduction
- 20.2 Biosensor classification for disease diagnosis
- 20.3 Biomarkers
- 20.4 Application of biosensors in disease detection
- 20.5 The market trend of biosensors in disease detection
- 20.6 Research trends of novel biosensors in disease detection
- 20.7 Advantages of use of biosensors in the field of disease detection
- 20.8 Designing and advancements of biosensor design
- 20.9 Biosensor ligands used for disease diagnosis
- 20.10 Detection of pathogenic organisms in diseases by biosensors
- 20.11 Nanoscience and disease biosensor
- 20.12 Conclusion
- 20.13 Future aspects
- References
- Chapter 21. Cancer diagnosis by biosensor-based devices: types and challenges
- Abstract
- 21.1 Introduction
- 21.2 Disadvantages of conventional methods of cancer detection
- 21.3 Cancer biomarkers
- 21.4 Need of biosensors for cancer diagnosis
- 21.5 Fabrication strategies for cancer biosensors
- 21.6 Biosensors for cancer detection
- 21.7 Structure of cancer biosensor
- 21.8 Novel biosensors
- 21.9 Cell and tissue-based biosensors
- 21.10 Biosensors and nanotechnology
- 21.11 Challenges
- 21.12 Future aspects
- References
- Chapter 22. Miniaturized devices for point-of-care testing/miniaturization and integration with microfluidic systems
- Abstract
- 22.1 Introduction
- 22.2 Detection of infectious and chronic diseases
- 22.3 Role of nanotechnology in the development of miniaturized devices
- 22.4 Integration of microfluidics with miniaturized point-of-care systems
- 22.5 Microfluidics as an emerging platform for point-of-care diagnosis
- 22.6 Conclusion
- References
- Chapter 23. Integrated low-cost biosensor for rapid and point-of-care cancer diagnosis
- Abstract
- 23.1 Introduction
- 23.2 Cancer biomarkers
- 23.3 New low-cost point-of-care diagnostics for cancer detection
- 23.4 Conclusion
- References
- Chapter 24. Scope of biosensors, commercial aspects, and miniaturized devices for point-of-care testing from lab to clinics applications
- Abstract
- 24.1 Introduction
- 24.2 Scope of biosensors
- 24.3 Cancer biomarker detection
- 24.4 Biomarkers for predicting the outcome of various cancer immunotherapies
- 24.5 Miniaturized devices for point-of-care testing from lab to clinical applications
- 24.6 Miniaturized point-of-care biosensor for cancer diagnosis
- 24.7 Current status of point-of-care cancer diagnostic devices
- 24.8 Global market of point-of-care devices
- 24.9 Limitations and challenges in cancer diagnostics
- 24.10 Conclusions and future prospects
- Acknowledgments
- References
- Index
- Edition: 1
- Published: August 25, 2021
- Imprint: Academic Press
- No. of pages: 438
- Language: English
- Paperback ISBN: 9780128234242
- eBook ISBN: 9780128236512
RK
Raju Khan
Raju Khan is a Senior Principal Scientist and Professor, at CSIR-Advanced Materials and Processes Research Institute, Bhopal. He did his PhD in Chemistry in 2005 from Jamia Millia Islamia, Central University, New Delhi, and Postdoctoral researcher at the “Sensor Research Laboratory” University of the Western Cape, Cape Town. His current research involved synthesizing novel materials to fabricate electrochemical and fluorescence-based biosensors integrated with microfluidics to detect target disease risk biomarkers for health care monitoring. He has published over 150 papers in SCI journal, which attracted over 5500 citations as per Google Scholar, published 45 book chapters in the reputed book Elsevier and Taylor Francis, editing of 28 books from Elsevier and Taylor Francis, and his research has been highlighted in Nature India. He has supervised 5 PhD and 30 undergraduate/postgraduate theses and has supervised 4 numbers of postdoctoral fellows under the scheme of N-PDF, CSIR-Nehru Fellowship, and DST-Women Scientist Projects.
AP
Arpana Parihar
SS